These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3048217)

  • 1. Immunologically mediated disease of the airways after pulmonary transplantation.
    Griffith BP; Paradis IL; Zeevi A; Rabinowich H; Yousem SA; Duquesnoy RJ; Dauber JH; Hardesty RL
    Ann Surg; 1988 Sep; 208(3):371-8. PubMed ID: 3048217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?
    Nørgaard MA; Andersen CB; Pettersson G
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):311-8. PubMed ID: 9761443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management.
    Bando K; Paradis IL; Similo S; Konishi H; Komatsu K; Zullo TG; Yousem SA; Close JM; Zeevi A; Duquesnoy RJ
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):4-13; discussion 13-4. PubMed ID: 7609567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection?
    Reinsmoen NL; Bolman RM; Savik K; Butters K; Hertz MI
    Transplantation; 1993 May; 55(5):1040-4. PubMed ID: 7684535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings.
    Reynaud-Gaubert M; Thomas P; Badier M; Cau P; Giudicelli R; Fuentes P
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1924-9. PubMed ID: 10852768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
    Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early lung leukocyte infiltration, HLA and adhesion molecule expression predict chronic rejection.
    Devouassoux G; Pison C; Drouet C; Pin I; Brambilla C; Brambilla E
    Transpl Immunol; 2001 Feb; 8(4):229-36. PubMed ID: 11316065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia pneumoniae infection after lung transplantation.
    Glanville AR; Gencay M; Tamm M; Chhajed P; Plit M; Hopkins P; Aboyoun C; Roth M; Malouf M
    J Heart Lung Transplant; 2005 Feb; 24(2):131-6. PubMed ID: 15701426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for the development of obliterative bronchiolitis after lung transplantation.
    Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J
    J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-16 in the airways of lung allograft recipients with acute rejection or obliterative bronchiolitis.
    Laan M; Lindén A; Riise GC
    Clin Exp Immunol; 2003 Aug; 133(2):290-6. PubMed ID: 12869037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
    Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchiolitis obliterans and airways obstruction associated with graft-versus-host disease.
    Epler GR
    Clin Chest Med; 1988 Dec; 9(4):551-6. PubMed ID: 3069287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation.
    Medoff BD; Seung E; Wain JC; Means TK; Campanella GS; Islam SA; Thomas SY; Ginns LC; Grabie N; Lichtman AH; Tager AM; Luster AD
    J Exp Med; 2005 Jul; 202(1):97-110. PubMed ID: 15998790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of obliterative bronchiolitis and determinants of outcome in 139 pulmonary retransplant recipients.
    Novick RJ; Schäfers HJ; Stitt L; Andréassian B; Duchatelle JP; Klepetko W; Hardesty RL; Frost A; Patterson GA
    J Thorac Cardiovasc Surg; 1995 Nov; 110(5):1402-13; discussion 1413-4. PubMed ID: 7475192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathological changes in the airways of stable lung transplant recipients.
    Snell GI; Ward C; Wilson JW; Orsida B; Williams TJ; Walters EH
    Thorax; 1997 Apr; 52(4):322-8. PubMed ID: 9196513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung transplantation for cystic fibrosis: 6-year follow-up.
    Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
    J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of obliterative bronchiolitis and occlusive vascular disease of patients following heart-lung transplantation.
    Scott JP; Higenbottam TW; Clelland C; Hutter JA; Stewart S; Otulana BA; Wallwork J
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2592-3. PubMed ID: 2539680
    [No Abstract]   [Full Text] [Related]  

  • 18. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.
    Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB
    Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic rejection in single-lung transplantation manifested by obliterative bronchiolitis.
    LoCicero J; Robinson PG; Fisher M
    J Thorac Cardiovasc Surg; 1990 Jun; 99(6):1059-62. PubMed ID: 2359323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen-DR13 and DR15 are associated with short-term lung transplant outcomes.
    Gracon AS; Liang TW; Rothhaar K; Wu J; Wilkes DS
    J Surg Res; 2016 Jun; 203(1):82-90. PubMed ID: 27338538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.